The GSK share price jumps 6% on positive FY 2024 results. Is it a stock to consider now?
Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results.
Bunge shares fall over 5% as Q4 results miss estimates, 2025 outlook disappoints
NEW YORK - Bunge Global SA (NYSE: NYSE:BG) reported fourth quarter earnings that fell short of analyst expectations, sending shares down 3.76% in early trading Wednesday.
Novo Nordisk beats in Q4 as Wegovy sales more than double
Novo Nordisk (NVO) reported better-than-expected operating profits for Q4 2024 on Wednesday, thanks mainly to its GLP-1 drugs, including its popular weight loss therapy Wegovy, which added DKK 19.9B ...
Disney+ and Hulu Swing to Combined Profit of $293 Million in Q1
Disney posted a 35% increase in earnings per share and 5% increase in total revenue in its first quarter of 2025, boosted by strong box-office performance led by “Moana 2,” which has topped $1 billion ...